Two Sigma Securities
VKTX icon

Two Sigma Securities’s Viking Therapeutics VKTX Stock Holding History

Two Sigma Securities’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$521K Buy
+13,365
New +$432K 0.05% 562
2026
Q1 		– Sell
-9,676
Closed -$340K – 2236
2025
Q4 		$340K Buy
+9,676
New +$343K 0.05% 573
2024
Q3 		– Sell
-6,157
Closed -$326K – 3690
2024
Q2 		$326K Buy
6,157
+3,491
+131% +$229K ﹤0.01% 1917
2024
Q1 		$219K Buy
+2,666
New +$119K ﹤0.01% 2262
2017
Q4 		– Sell
-11,481
Closed -$22K – 2031
2017
Q3 		$22K Buy
+11,481
New +$13K ﹤0.01% 824

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Two Sigma Securities's VKTX Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Viking Therapeutics (VKTX) in Q2 2026: 13,365 shares worth $521K. The stake represents 0.05% of the portfolio and ranks #562 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in VKTX as recently as Q4 2025.

Two Sigma Securities first reported a position in VKTX in Q3 2017 and has held it in 5 quarters since. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Two Sigma Securities held 13,365 shares of Viking Therapeutics worth $521K as of Q2 2026.
  • Viking Therapeutics was a new Two Sigma Securities position in Q2 2026.
  • Viking Therapeutics made up 0.05% of Two Sigma Securities's portfolio in Q2 2026, its #562 holding.
  • Two Sigma Securities first reported a position in Viking Therapeutics in Q3 2017 and has held it in 5 quarters since.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.